Gro for Tissue Therapies
Wednesday, 09 July, 2008
Tissue Therapies [ASX: TIS] is to conduct a clinical trial of its VitroGro wound healing technology in Perth, to begin in August.
The trial will be conducted at UWA Professor Chris Stacey's wound care clinic in Perth, and will concentrate on venous ulcers.
Tissue Therapies is also awaiting regulatory approval to conduct another group of trials in Toronto, Canada, which will concentrate on diabetic and pressure ulcers (bed sores). Preparation for both trials is complete.
VitroGro has already undergone more than six years of laboratory research using live human skin cells. The technology was developed from research at Queensland University of Technology's Institute for Health and Biomedical Innovation (IHBI).
Scientists search for cystitis pain 'off switch'
By targeting certain pain receptors in the bladder, Australian scientists believe that the...
Australia's first cases of H5 avian influenza confirmed
Positive results for H5 avian influenza (bird flu) have been confirmed in two seabirds found in...
AusBiotech partners with Tenmile
Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...
